Go Pro

Akso Health Group (AHG) Competitors

Akso Health Group logo
$0.87 +0.02 (+2.80%)
As of 09/3/2026 03:19 PM Eastern

AHG vs. CCO, TBLA, MNTN, PUBM, and IBTA

Should you buy Akso Health Group stock or one of its competitors? Akso Health Group's main competitors and comparable companies include Clear Channel Outdoor (CCO), Taboola.com (TBLA), MNTN (MNTN), PubMatic (PUBM), and Ibotta (IBTA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "advertising" industry.

How does Akso Health Group compare to Clear Channel Outdoor?

Akso Health Group (NASDAQ:AHG) and Clear Channel Outdoor (NYSE:CCO) are both small-cap communication services companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

In the previous week, Clear Channel Outdoor had 2 more articles in the media than Akso Health Group. MarketBeat recorded 3 mentions for Clear Channel Outdoor and 1 mentions for Akso Health Group. Clear Channel Outdoor's average media sentiment score of 1.46 beat Akso Health Group's score of -0.71 indicating that Clear Channel Outdoor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Akso Health Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
Clear Channel Outdoor
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

1.2% of Akso Health Group shares are owned by institutional investors. Comparatively, 85.5% of Clear Channel Outdoor shares are owned by institutional investors. 7.7% of Clear Channel Outdoor shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Akso Health Group has a beta of -1.07, meaning that its share price is 207% less volatile than the broader market. Comparatively, Clear Channel Outdoor has a beta of 1.95, meaning that its share price is 95% more volatile than the broader market.

Akso Health Group has a net margin of 0.00% compared to Clear Channel Outdoor's net margin of -6.31%.

Company Net Margins Return on Equity Return on Assets
Akso Health GroupN/A N/A N/A
Clear Channel Outdoor -6.31%N/A -2.08%

Clear Channel Outdoor has higher revenue and earnings than Akso Health Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Akso Health Group$13.83M34.87-$18.67MN/AN/A
Clear Channel Outdoor$1.60B0.76$19.94M-$0.21N/A

Clear Channel Outdoor has a consensus target price of $2.29, suggesting a potential downside of 3.70%. Given Clear Channel Outdoor's stronger consensus rating and higher possible upside, analysts clearly believe Clear Channel Outdoor is more favorable than Akso Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Akso Health Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Clear Channel Outdoor
2 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Summary

Clear Channel Outdoor beats Akso Health Group on 9 of the 12 factors compared between the two stocks.

How does Akso Health Group compare to Taboola.com?

Taboola.com (NASDAQ:TBLA) and Akso Health Group (NASDAQ:AHG) are both small-cap communication services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

42.9% of Taboola.com shares are owned by institutional investors. Comparatively, 1.2% of Akso Health Group shares are owned by institutional investors. 20.6% of Taboola.com shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Taboola.com had 25 more articles in the media than Akso Health Group. MarketBeat recorded 26 mentions for Taboola.com and 1 mentions for Akso Health Group. Taboola.com's average media sentiment score of 0.08 beat Akso Health Group's score of -0.71 indicating that Taboola.com is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Taboola.com
2 Very Positive mention(s)
1 Positive mention(s)
22 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Akso Health Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative

Taboola.com has a net margin of 6.05% compared to Akso Health Group's net margin of 0.00%. Taboola.com's return on equity of 12.15% beat Akso Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Taboola.com6.05% 12.15% 7.22%
Akso Health Group N/A N/A N/A

Taboola.com has higher revenue and earnings than Akso Health Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Taboola.com$1.91B0.51$42.28M$0.409.68
Akso Health Group$13.83M34.87-$18.67MN/AN/A

Taboola.com has a beta of 1.48, suggesting that its share price is 48% more volatile than the broader market. Comparatively, Akso Health Group has a beta of -1.07, suggesting that its share price is 207% less volatile than the broader market.

Taboola.com presently has a consensus target price of $5.75, suggesting a potential upside of 48.58%. Given Taboola.com's stronger consensus rating and higher possible upside, research analysts plainly believe Taboola.com is more favorable than Akso Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Taboola.com
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57
Akso Health Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Taboola.com beats Akso Health Group on 13 of the 14 factors compared between the two stocks.

How does Akso Health Group compare to MNTN?

MNTN (NYSE:MNTN) and Akso Health Group (NASDAQ:AHG) are both small-cap communication services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.

MNTN has higher revenue and earnings than Akso Health Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MNTN$290.09M2.86-$6.43M$0.7118.87
Akso Health Group$13.83M34.87-$18.67MN/AN/A

MNTN has a beta of 0.94, suggesting that its stock price is 6% less volatile than the broader market. Comparatively, Akso Health Group has a beta of -1.07, suggesting that its stock price is 207% less volatile than the broader market.

In the previous week, MNTN and MNTN both had 1 articles in the media. MNTN's average media sentiment score of 0.75 beat Akso Health Group's score of -0.71 indicating that MNTN is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MNTN
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Akso Health Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative

72.9% of MNTN shares are held by institutional investors. Comparatively, 1.2% of Akso Health Group shares are held by institutional investors. 19.6% of MNTN shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

MNTN has a net margin of 18.00% compared to Akso Health Group's net margin of 0.00%. MNTN's return on equity of 18.85% beat Akso Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MNTN18.00% 18.85% 15.48%
Akso Health Group N/A N/A N/A

MNTN currently has a consensus price target of $18.65, indicating a potential upside of 39.18%. Given MNTN's stronger consensus rating and higher possible upside, equities analysts plainly believe MNTN is more favorable than Akso Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MNTN
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.75
Akso Health Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

MNTN beats Akso Health Group on 13 of the 14 factors compared between the two stocks.

How does Akso Health Group compare to PubMatic?

PubMatic (NASDAQ:PUBM) and Akso Health Group (NASDAQ:AHG) are both small-cap communication services companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

64.3% of PubMatic shares are owned by institutional investors. Comparatively, 1.2% of Akso Health Group shares are owned by institutional investors. 27.8% of PubMatic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

PubMatic has higher revenue and earnings than Akso Health Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PubMatic$282.93M2.73-$14.46M-$0.30N/A
Akso Health Group$13.83M34.87-$18.67MN/AN/A

PubMatic presently has a consensus target price of $18.25, suggesting a potential upside of 7.61%. Given PubMatic's stronger consensus rating and higher probable upside, equities analysts plainly believe PubMatic is more favorable than Akso Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PubMatic
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75
Akso Health Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

PubMatic has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market. Comparatively, Akso Health Group has a beta of -1.07, suggesting that its stock price is 207% less volatile than the broader market.

In the previous week, PubMatic had 1 more articles in the media than Akso Health Group. MarketBeat recorded 2 mentions for PubMatic and 1 mentions for Akso Health Group. PubMatic's average media sentiment score of 0.66 beat Akso Health Group's score of -0.71 indicating that PubMatic is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PubMatic
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Akso Health Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative

Akso Health Group has a net margin of 0.00% compared to PubMatic's net margin of -4.66%. Akso Health Group's return on equity of 0.00% beat PubMatic's return on equity.

Company Net Margins Return on Equity Return on Assets
PubMatic-4.66% -5.41% -1.99%
Akso Health Group N/A N/A N/A

Summary

PubMatic beats Akso Health Group on 10 of the 14 factors compared between the two stocks.

How does Akso Health Group compare to Ibotta?

Ibotta (NYSE:IBTA) and Akso Health Group (NASDAQ:AHG) are both small-cap communication services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

1.2% of Akso Health Group shares are held by institutional investors. 20.9% of Ibotta shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Ibotta presently has a consensus target price of $36.50, indicating a potential downside of 1.86%. Given Ibotta's stronger consensus rating and higher probable upside, equities analysts clearly believe Ibotta is more favorable than Akso Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ibotta
3 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.75
Akso Health Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Ibotta has a beta of -0.25, meaning that its share price is 125% less volatile than the broader market. Comparatively, Akso Health Group has a beta of -1.07, meaning that its share price is 207% less volatile than the broader market.

Ibotta has higher revenue and earnings than Akso Health Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ibotta$342.39M2.19$3.58M-$0.47N/A
Akso Health Group$13.83M34.87-$18.67MN/AN/A

In the previous week, Ibotta had 6 more articles in the media than Akso Health Group. MarketBeat recorded 7 mentions for Ibotta and 1 mentions for Akso Health Group. Ibotta's average media sentiment score of 1.16 beat Akso Health Group's score of -0.71 indicating that Ibotta is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ibotta
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Akso Health Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative

Akso Health Group has a net margin of 0.00% compared to Ibotta's net margin of -3.21%. Akso Health Group's return on equity of 0.00% beat Ibotta's return on equity.

Company Net Margins Return on Equity Return on Assets
Ibotta-3.21% -4.74% -2.55%
Akso Health Group N/A N/A N/A

Summary

Ibotta beats Akso Health Group on 9 of the 14 factors compared between the two stocks.

Get Akso Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for AHG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AHG vs. The Competition

MetricAkso Health GroupMedia IndustryCommunication Services SectorNASDAQ Exchange
Market Cap$469.08M$3.15B$32.88B$12.73B
Dividend YieldN/A5.47%5.33%8.86%
P/E RatioN/A32.2724.3225.25
Price / Sales34.8735.3962.6197.64
Price / CashN/A15.9220.4152.26
Price / Book2.659.4911.616.14
Net Income-$18.67M-$45.84M$1.10B$349.01M
7 Day Performance1.98%-0.21%-0.11%-0.31%
1 Month Performance-36.22%4.03%0.63%0.64%
1 Year Performance-46.39%0.72%-2.94%14.83%

Akso Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AHG
Akso Health Group
0.5449 of 5 stars
$0.87
+2.8%
N/A-49.2%$469.08M$13.83MN/A40
CCO
Clear Channel Outdoor
1.3939 of 5 stars
$2.34
-2.1%
$2.29
-2.1%
+88.1%$1.19B$1.60BN/A1,900
TBLA
Taboola.com
4.7277 of 5 stars
$3.81
+1.1%
$5.75
+50.9%
+14.8%$960.56M$1.96B9.532,000
MNTN
MNTN
4.2502 of 5 stars
$13.21
+4.8%
$18.65
+41.2%
-35.9%$817.57M$290.09M18.61502
PUBM
PubMatic
2.8753 of 5 stars
$17.10
+4.6%
$18.25
+6.7%
+101.9%$778.91M$282.93MN/A1,030

Related Companies and Tools


This page (NASDAQ:AHG) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners